HSP90B2P and neoplasm: These approaches may involve the use of HSP inhibitors, nanocoating for controlled light conversion, and the employment of suitable in vivo models.[188, 191] By incorporating HSP inhibitors, the defensive mechanisms of tumor cells can be targeted, potentially sensitizing them to NO‐based therapies.